FDA Orders Amgen To Make Changes To Label Of Anemia Drug

July 31, 2008

The U.S. Food and Drug Administration (FDA) has told Amgen Inc. that they need to make changes to the label of their anemia drug, Aranesp......Washington (ChattahBox) – The U.S. Food and Drug Administration (FDA) has told Amgen Inc. that they need to make changes to the label of their anemia drug, Aranesp.

The FDA is ordering changes to be made to the drug from Amgen Inc., as well as similar anemia drugs.

This comes after the revelation that they can pose a risk to cancer patients.

The FDA wants the labels revised, and made to state that the drugs are not meant for cancer patients who are going through chemotherapy.

Also, they must add that people with hemoglobin levels greater than, or equal to, 10 grams per deciliter, should not take the drug.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.